Crossmark

Unstable Housing Still a Barrier to Receiving HCV Treatment in France (ANRS CO13 HEPAVIH Cohort)

Crossref DOI link: https://doi.org/10.1007/s10620-017-4703-y

Published Online: 2017-08-05

Published Print: 2017-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Yaya, I. https://orcid.org/0000-0002-2554-6515
Roux, P.

Marcellin, F.

Salmon-Ceron, D.

Carrieri, M. P.
Funding

Funding for this research was provided by:

ANRS

Abbott France

GlaxoSmithKline

Roche

Schering-Plough

INSERM
License Information

License valid from 2017-08-05